FIELD: medicine, pharmaceutics.
SUBSTANCE: there are produced new diazepane substituted compounds representing various heterocyclic systems, including condensed, pharmaceutical compositions containing said compounds.
EFFECT: producing the compounds and compositions for preventing and treating neurological and mental disorders and diseases with involved orexin receptors.
13 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS OF SUBSTITUTED DIAZEPANES AS ANTAGONISTS OF OREXIN RECEPTORS | 2007 |
|
RU2561727C2 |
PYRIDYL-PIPERIDINE ANTAGONISTS OF OREXIN RECEPTORS | 2008 |
|
RU2470021C2 |
HETERO-AROMATIC METHYLIC DERIVATIVE OF CYCLIC AMINE | 2013 |
|
RU2639869C2 |
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2 NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS AND USE THEREOF | 2012 |
|
RU2610262C2 |
CETP INHIBITORS | 2006 |
|
RU2513107C2 |
3-AMINOPYRROLIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | 2003 |
|
RU2355679C2 |
AKT ACTIVITY INHIBITORS | 2006 |
|
RU2421454C2 |
TRIAZOLE[4,5-d]PYRIMIDINE DERIVATIVES AND USES THEREOF AS PUTINOCEPTOR ANTAGONISTS | 2002 |
|
RU2317084C2 |
2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
Authors
Dates
2012-08-20—Published
2007-11-30—Filed